Skip to main content

and
  1. No Access

    Article

    Disposition of azapropazone in chronic renal and hepatic failure

    The disposition of azapropazone 600 mg i.v. was investigated in 6 healthy subjects, 13 patients with cirrhosis and 8 patients with renal failure. In healthy subjects the elimination half-life was 12.2±2.1 h (m...

    K. -H. Breuing, H. -J. Gilfrich, T. Meinertz in European Journal of Clinical Pharmacology (1981)